ALGN vs. STE, ZBH, SNN, MSA, ESTA, AVNS, INGN, EW, ARGX, and WAT
Should you be buying Align Technology stock or one of its competitors? The main competitors of Align Technology include STERIS (STE), Zimmer Biomet (ZBH), Smith & Nephew (SNN), MSA Safety (MSA), Establishment Labs (ESTA), Avanos Medical (AVNS), Inogen (INGN), Edwards Lifesciences (EW), argenx (ARGX), and Waters (WAT).
STERIS (NYSE:STE) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, community ranking, institutional ownership, media sentiment, dividends, valuation and profitability.
STERIS has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.66, indicating that its share price is 66% more volatile than the S&P 500.
STERIS presently has a consensus target price of $241.60, suggesting a potential upside of 3.83%. Align Technology has a consensus target price of $353.00, suggesting a potential upside of 30.02%. Given STERIS's higher probable upside, analysts plainly believe Align Technology is more favorable than STERIS.
In the previous week, STERIS had 7 more articles in the media than Align Technology. MarketBeat recorded 17 mentions for STERIS and 10 mentions for Align Technology. STERIS's average media sentiment score of 1.05 beat Align Technology's score of 0.77 indicating that Align Technology is being referred to more favorably in the news media.
Align Technology has lower revenue, but higher earnings than STERIS. Align Technology is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.
94.7% of STERIS shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 1.0% of STERIS shares are owned by company insiders. Comparatively, 0.6% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Align Technology has a net margin of 11.80% compared to Align Technology's net margin of 6.95%. STERIS's return on equity of 14.15% beat Align Technology's return on equity.
Align Technology received 441 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 69.64% of users gave Align Technology an outperform vote while only 58.51% of users gave STERIS an outperform vote.
Summary
Align Technology beats STERIS on 12 of the 17 factors compared between the two stocks.
Get Align Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Align Technology Competitors List
Related Companies and Tools